Ajaypal Singh to Randomized Controlled Trials as Topic
This is a "connection" page, showing publications Ajaypal Singh has written about Randomized Controlled Trials as Topic.
Connection Strength
1.703
-
Con: Randomized controlled trials (RCT) have failed in the study of dialysis methods. Nephrol Dial Transplant. 2013 Apr; 28(4):826-32; discussion 832.
Score: 0.402
-
Pro: The value of randomized controlled studies in dialysis methods. Nephrol Dial Transplant. 2013 Apr; 28(4):834-5; discussion 835-6.
Score: 0.402
-
Diabetes, anemia and CKD: Why TREAT? Curr Diab Rep. 2010 Aug; 10(4):291-6.
Score: 0.334
-
Anaemia of CKD--the CHOIR study revisited. Nephrol Dial Transplant. 2007 Jul; 22(7):1806-10.
Score: 0.265
-
What is causing the mortality in treating the anemia of chronic kidney disease: erythropoietin dose or hemoglobin level? Curr Opin Nephrol Hypertens. 2010 Sep; 19(5):420-4.
Score: 0.084
-
Does TREAT give the boot to ESAs in the treatment of CKD anemia? J Am Soc Nephrol. 2010 Jan; 21(1):2-6.
Score: 0.080
-
The target hemoglobin in patients with chronic kidney disease. Nephrol News Issues. 2006 Dec; 20(13):29-30.
Score: 0.065
-
Rationale--Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT): evolving the management of cardiovascular risk in patients with chronic kidney disease. Am Heart J. 2005 Mar; 149(3):408-13.
Score: 0.057
-
Uncertainty in the treatment of anemia in chronic kidney disease. Rev Cardiovasc Med. 2005; 6 Suppl 3:S35-41.
Score: 0.014